Lack of effect of methotrexate in budesonide-refractory collagenous colitis

Clinical and Experimental Gastroenterology

Volumn 6, Issue 1, 2013, Pages 149-152

  Münch, Andreas ^a   Bohr, Johan ^b,c   Vigren, Lina ^d   Tysk, Curt ^b,c   Ström, Magnus ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c ÖREBRO UNIVERSITY   (Sweden)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Diarrhea; Health related quality of life; Microscopic colitis; MTX; Short health scale; Stools

Indexed keywords

BUDESONIDE; COLESTYRAMINE; LOPERAMIDE; MESALAZINE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CHILL; CLINICAL ARTICLE; CLINICAL PROTOCOL; COLLAGENOUS COLITIS; COLON BIOPSY; COLONOSCOPY; CONJUNCTIVITIS; DEFECATION; DEFECATION HABIT; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG WITHDRAWAL; ERYTHEMA; EYE EDEMA; FACE EDEMA; FATIGUE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOOD DISORDER; MOON FACE; NAUSEA; OPEN STUDY; OUTCOME ASSESSMENT; QUALITY OF LIFE; RATING SCALE; REMISSION; SHORT COURSE THERAPY; SHORT HEALTH SCALE; SIDE EFFECT; TREATMENT DURATION; WEIGHT GAIN;

EID: 84883629239     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S48201     Document Type: Article

References (16)

1. Warren BF, Edwards CM, Travis S P. 'Microscopic colitis': classifcation and terminology. Histopatholog y. 2002;40(4):374-376.
2. Olesen M, Eriksson S, Bohr J, Järnerot G, Tysk C. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut. 2004;53(3):346-350.
3. Pardi DS, Loftus EV Jr, Smyrk TC, et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut. 2007;56(4):504-508.
4. Miehlke S, Heymer P, Bethke B, et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterolog y. 2002;123(4):978-984.
5. Bonderup OK, Hansen JB, Birket-Smith L, Vestergaard V, Teglbjaerg PS, Fallingborg J. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut. 2003;52(2):248-251.
6. Baert F, Schmit A, D'Haens G, et al; Belgian IBD Research Group; Codali Brussels. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology. 2002;122(1):20-25.
7. Chande N, MacDonald JK, McDonald J W. Interventions for treating microscopic colitis: a Cochrane Infammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol. 2009;104(1):235-241
8. Miehlke S, Madisch A, Voss C, et al. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther. 2005;22(11-12):1115-1119.
9. Bonderup OK, Hansen JB, Teglbjaerg PS, Christensen LA, Fallingborg J F. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut. 2009;58(1):68-72.
10. Pardi DS, Loftus EV Jr, Tremaine WJ, Sandborn WJ. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterolog y. 2001;120(6):1483-1484.
11. Riddell J, Hillman L, Chiragakis L, et al. Collagenous colitis: oral low-dose methotrexate for patients with diffcult symptoms: long-term outcomes. J Gastroenterol Hepatol. 2007;22(10):1589-1593.
12. Hjortswang H, Tysk C, Bohr J, et al. Defning clinical criteria for clinical remission and disease activity in collagenous colitis. Infamm Bowel Dis. 2009;15(12):1875-1881.
13. Hjortswang H, Järnerot G, Curman B, et al. The Short Health Scale: a valid measure of subjective health in ulcerative colitis. Scand J Gastroenterol. 2006;41:1196-1203.
14. Miehlke S, Madisch A, Bethke B, et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterolog y. 2008;135(5):1510-1516.
15. Dr Falk Pharma GmbH. Double-blind, randomised, placebo-controlled, multi-centre phase III clinical study on the efficacy and tolerability of budesonide capsules versus placebo for maintenance of remission in patients with collagenous colitis. In: EU Clinical Trials Register [website on the Internet]. London: European Medicines Agency; 2008 [completed 2013]. Available from: https://www.clinicaltrialsregister. eu/ctr-search/trial/2007-001315-31/SE. EudraCT number: 2007-001315-31. Accessed July 30, 2013.
16. Vigren L, Sjöberg K, Benoni C, et al. Is smoking a risk factor for collagenous colitis? Scand J Gastroenterol. 2011;46(11): 1334-1339.